Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Cyrex Laboratories LLC is managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This prosecution is assigned to 1 distinct examiner, MARCSISIN, ELLEN JEAN, and is located in 1 distinct art unit. The busiest examiner, MARCSISIN, ELLEN JEAN, is currently managing 1 busiest examiner pending action. The data shows a highly centralized prosecution for Cyrex Laboratories LLC, with the total of 1 pending office action being handled by a single examiner.
In the Biotechnology & Pharmaceuticals sector, this indicates a specific technical focus for the company's current patent application. The involvement of only 1 distinct examiner and 1 distinct art unit means that the prosecution process is streamlined and focused on a single point of contact. Practitioners should note that the outcome of the pending matter is entirely dependent on the review of MARCSISIN, ELLEN JEAN, as there are no other examiners or art units currently active in the portfolio. This centralized structure can simplify the management of the patent application but limits the ability to leverage different examiner viewpoints within the same technology area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARCSISIN, ELLEN JEAN | 1 | 34.5% | +49.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18634228 | Methods and Apparatus for Determination of Sensitivity to Wheat | MARCSISIN, ELLEN JEAN | 57d |
| Art Unit | Apps |
|---|---|
| 1677 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18634228 | Methods and Apparatus for Determination of Sensitivity to Wheat | MARCSISIN, ELLEN JEAN | 1677 | §103 | Non-Final OA | 57d | Pending | Apr 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial